A Study of Patients Treated With Erythropoietin Receptor Agonists for Anemia Who Developed Anti-erythropoietin Antibodies
Stopped The study never started due to zero enrolment
Conditions
Interventions
Sponsor
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.